Extract

The primary objective of this study is to compare the efficacy and safety of DuoTrav APS to DuoTrav, both dosed once-daily in the morning, in patients with open angle glaucoma or ocular hypertension.

Inclusion criteria

• Open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension

Links

• euctr
• ictrp